#کارنامه_بهداشت
#کارنامه
تبریک به خانم سمانه جوادی فر
دانشجوی عزیزم، برای کسب رتبه ۷ سهمیه در آزمون ارشد ژنتیک پزشکی
با آرزوی درخشش های مداوم برای این دختر نازنینم 🥹🧬🧬🧬💪
✅ @GeneMedia
BY MedicalGenetics (Brinsica)
However, analysts are positive on the stock now. “We have seen a huge downside movement in the stock due to the central electricity regulatory commission’s (CERC) order that seems to be negative from 2014-15 onwards but we cannot take a linear negative view on the stock and further downside movement on the stock is unlikely. Currently stock is underpriced. Investors can bet on it for a longer horizon," said Vivek Gupta, director research at CapitalVia Global Research.
Importantly, that investor viewpoint is not new. It cycles in when conditions are right (and vice versa). It also brings the ineffective warnings of an overpriced market with it.Looking toward a good 2022 stock market, there is no apparent reason to expect these issues to change.
MedicalGenetics Brinsica from us